shows the repeatability of the lipidomics analysis and clearly differentiates PMs from CMs on PC1, and the three cell types from each other on PC2. The loadings plot on the right shows the specific components that contribute most strongly to the separation. For PC1, variables correlating positively for PMs were cholesterol, sphingolipids and relatively saturated lipids. The table of principle component scores and loadings is  table S1 . (E) Isolated PMs are depleted of intracellular organelle markers. PM and CM preparations were subjected to Western blotting for markers of various organelles. Protein content in both preparations was quantified by BCA analysis, then equal amounts (15ug) were run on 4-15% gradient SDS-PAGE gels. PMs are rich in the PM markers Na + /K + ATPase and caveolin and depleted of calnexin (endoplasmic reticulum; ER), Sec61a (ER), Hexokinase II (mitochondria), LAMP1 (lysosomes), GM130 (Golgi), and GOLGA7 (Golgi). Mean ± SD for three individual human donors. ***p<0.001, * p<0.05. Triacylglycerides accumulate in adipocytes, therefore the abundance of these neutral lipids is a bona fide readout of adipogenic differentiation. DHA supplementation had no effect on TAG accumulation in hMSCs differentiated into adipocytes for 14 days. (E) Genes regulated by CEBPa, a central adipogenic transcription factor, were upregulated during adipogenic differentiation (see Materials and Methods), but not enhanced by DHA supplementation. Shown are fold changes compared to untreated undifferentiated controls with mean ± SD expression change. The same effects were observed for PPAR-target genes (table S4) . Data in C and D are mean ± SD for 3 independent experiments on 3 human donors.
Discussion regarding lack of effect of DHA-mediated lipidomic remodeling and associated Akt activation on adipogenic differentiation: The lack of effect of DHA-mediated membrane remodeling on adipogenic differentiation is somewhat surprising, given that (a) DHA upregulates Akt phosphorylation (Fig ??) ; and (b) Akt phosphorylation has been widely associated with adipocyte differentiation. The effects of DHA are lineage-specific probably because wholesale membrane remodeling likely affects many other signaling nodes originating at the plasma membrane. In the context of osteogenic differentiation, several aspects of the osteogenic membrane phenotype (composition, biophysical properties, Akt phosphorylation, and organization) are mimicked by DHA feeding of MSCs, thereby promoting differentiation. This effect requires enhanced Akt phosphorylation ( Fig. 5F ), but also likely depends on the specifics of the signaling network induced during osteoblast differentiation. In the case of adipogenesis, key aspects of the adipocyte membrane phenotype (see Fig. 1 ) are not reproduced by DHA feeding, rather opposed, thus potentially counteracting the effect of Akt activation. Furthermore, in adipogenic differentiation, the overall signaling network is certainly altered (e.g. by inclusion of insulin and hormonal factors in the differentiation media) and therefore the effects of microdomain stabilization by DHA would likely also be different. The likely explanation is that a rapid (within minutes), robust spike of Akt phosphorylation is induced by the adipogenic induction medium (5). This burst of signaling leads to induction of PPARg and C/EBPa expression, which then constitute a positive-feedback loop to reinforce each other's expression. Since expression of these transcription factors is sufficient for adipogenic differentiation even in the complete absence of Akt (6), adipogenesis is decoupled from Akt signaling after PPARg/CEBPa expression, and therefore any increase in Akt activation induced by DHA supplementation would not be expected to have significant effects. isolated from adipogenic, osteogenic, and undifferentiated cells (fig. S3 ). Shown are the two principles components that account for the most variability in the data (37% by PC1 and 24% by PC2). Fig. 1I) . Shown is PC1, the component that accounts for the most variation between the PMs of Adipo, Osteo, and Undiff cells (45%). Osteo PM have a high PC1 score, suggesting they are enriched in longer and more polyunsaturated lipids, while Adipo PMs have a negative PC1 score which corresponds to shorter and more saturated (0-2 saturations) lipids. Fig. 2L) . Shown are the two components that account for the most variability in the data. DHA treatment induced a downward shift on PC2, reflective of more a more osteoblastic membrane composition in undiff MSCs (i.e. longer and more polyunsaturated lipids). -0.01 0.16 GL-C-36 -0.12 -0.11 GL-C-38 0.07 -0.25 GL-C-40 0.15 -0.12 GPL-C-28 -0.13 -0.05 GPL-C-30 -0.20 -0.08 GPL-C-31 -0.05 0.02 GPL-C-32 -0.22 0.01 GPL-C-33 0.06 0.17 GPL-C-34 -0.12 0.24 GPL-C-35 0.11 0.17 GPL-C-36 0.13 0.20 GPL-C-37 0.19 0.06 GPL-C-38 0.19 -0.11 GPL-C-39 0.21 0.02 GPL-C-40 0.16 -0.20 GPL-C-41 0.06 -0.10 GPL-C-42 0.18 0.02 GPL-C-44 0.10 -0.12 SL-C-28 0.00 0.00 SL-C-31 -0.06 -0.04 SL-C-32 0.11 -0.04 SL-C-33 0.02 -0.02 SL-C-34 0.19 -0.08 SL-C-35 0.19 -0.02 SL-C-36 0.02 0.05 SL-C-37 0.00 0.00 SL-C-38 0.13 0.12 SL-C-39 0.12 -0.01 SL-C-40 0.10 0.09 SL-C-41 0.11 0.16 SL-C-42 0.07 0.08 SL-C-43 0.18 0.12 SL-C-44 0.15 0.03 
SUPPLEMENTARY TABLES table S1. Variables and principal component correlation coefficients (loadings) for PCA of CM and PM lipids

Variables
